← All Sponsors
SPONSOR

Stony Brook University

Total Trials
5
Recruiting
5
Phases
Phase 3, Phase 4

Stony Brook University is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Thyroid Nodule, Ischemic Stroke, Postpartum Hemorrhage, Cancer.

The trial portfolio spans Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Stony Brook University

How many clinical trials has Stony Brook University sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Stony Brook University, of which 5 are actively recruiting participants. These trials cover conditions including Thyroid Nodule, Ischemic Stroke, Postpartum Hemorrhage. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Stony Brook University research focus on?
Stony Brook University clinical trials span Thyroid Nodule, Ischemic Stroke, Postpartum Hemorrhage, Cancer, Dyspepsia, and additional conditions. The research pipeline includes Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Stony Brook University clinical trial?
To participate in a Stony Brook University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Stony Brook University trials with current recruitment status updated daily.

Clinical Trials by Stony Brook University

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology